ALLIANCE C80702

Primary Category:

Treatment Protocols

Disease Category:

Colon, Gastrointestinal

Status:

Closed

A Phase III Trial of 6 versus 12 Treatments of Adjuvant FOLFOX Plus Celecoxib or Placebo for Patients With Resected Stage III Colon Cancer

CALGB 80702 is permanently closed to new patient accrual effective, November 20. 2015 at 4:30 PM ET.

NCT#01150045